We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Ollie's Bargain Outlet
OLLI
$4.27B
| $2.58M | ﹤0.01% |
19,541
-5,743
| -23% | -$658K |
|
877
Antero Midstream
AM
$10.6B
| $2.56M | ﹤0.01% |
135,352
-50,048
| -27% | -$894K |
|
|
ALEX
878
DELISTED
Alexander & Baldwin
ALEX
| $2.54M | ﹤0.01% |
142,582
+140,260
| +6,040% | +$2.44M |
|
879
MannKind Corp
MNKD
$1.27B
| $2.52M | ﹤0.01% |
673,739
-665,560
| -50% | -$2.93M |
|
880
Nasdaq
NDAQ
$55.8B
| $2.52M | ﹤0.01% |
28,140
+7,841
| +39% | +$626K |
|
881
Asbury Automotive
ABG
$3.82B
| $2.51M | ﹤0.01% |
10,524
+3,978
| +61% | +$909K |
|
|
CADE
882
DELISTED
Cadence Bank
CADE
| $2.51M | ﹤0.01% |
78,353
-39,475
| -34% | -$1.18M |
|
883
Forrester Research
FORR
$238M
| $2.5M | ﹤0.01% |
252,810
+2,446
| +1% | +$24.3K |
|
884
Glaukos
GKOS
$10.7B
| $2.46M | ﹤0.01% |
23,823
-3,786
| -14% | -$355K |
|
885
Oceaneering
OII
$5.02B
| $2.41M | ﹤0.01% |
116,146
-27,981
| -19% | -$540K |
|
886
FuelCell Energy
FCEL
$1.45B
| $2.4M | ﹤0.01% |
427,862
-103,753
| -20% | -$504K |
|
887
PagerDuty
PD
$1.06B
| $2.38M | ﹤0.01% |
156,058
+138,867
| +808% | +$2.16M |
|
888
Interface
TILE
$2.19B
| $2.37M | ﹤0.01% |
113,458
-20,785
| -15% | -$412K |
|
889
Avista
AVA
$3.16B
| $2.37M | ﹤0.01% |
62,389
+20,504
| +49% | +$809K |
|
890
SIGA Technologies
SIGA
$216M
| $2.37M | ﹤0.01% |
362,961
+1,991
| +0.6% | +$11.9K |
|
|
NVO
891
Novo Nordisk
NVO
$203B
| $2.37M | ﹤0.01% |
34,286
-85,040
| -71% | -$5.78M |
|
892
Parsons
PSN
$5.23B
| $2.34M | ﹤0.01% |
32,592
-1,443
| -4% | -$95.3K |
|
893
Lemonade
LMND
$4.18B
| $2.33M | ﹤0.01% |
+53,250
| New | +$1.77M |
|
894
Curtiss-Wright
CW
$22B
| $2.33M | ﹤0.01% |
4,767
+84
| +2% | +$33.2K |
|
895
Minerva Neurosciences
NERV
$247M
| $2.32M | ﹤0.01% |
1,351,275
| – | – |
|
896
NiSource
NI
$19.6B
| $2.32M | ﹤0.01% |
57,604
-15,896
| -22% | -$623K |
|
897
EPR Properties
EPR
$4.55B
| $2.32M | ﹤0.01% |
39,831
-35,122
| -47% | -$1.85M |
|
898
BlackLine
BL
$1.93B
| $2.32M | ﹤0.01% |
40,980
-29,735
| -42% | -$1.54M |
|
899
STAG Industrial
STAG
$7.17B
| $2.3M | ﹤0.01% |
63,483
-56,046
| -47% | -$1.94M |
|
900
Energizer
ENR
$1.53B
| $2.3M | ﹤0.01% |
113,849
-7,938
| -7% | -$191K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.